Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.
about
Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialThe prevalence of drug resistance among treatment-naïve HIV-1-infected individuals in China during pre- and post- 2004Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.Participation in research involving novel sampling and study designs to identify acute HIV-1 infection among minority men who have sex with menFuture of phylogeny in HIV prevention.Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventionsTransmitted human immunodeficiency virus-1 drug resistance in a cohort of men who have sex with men in Belo Horizonte, Brazil--1996-2012Newly Acquired Infection with Multi-Drug Resistant HIV-1 in a Patient Adherent to Pre-Exposure Prophylaxis.Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999-2011.Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health.Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States
P2860
Q28547790-0AAA50C8-AFDB-4A29-A37B-7D31FB68EEF4Q35124860-96BA1619-66EA-4604-8A38-936B0CFFF2C9Q36174668-39B2FB31-6C14-4F63-8F23-B4002DC1EA57Q36543845-0454C5D6-0142-4697-9D5B-24CB2E5BD624Q36944979-D22854FB-2A58-40A0-8190-C78A25571E4BQ36945699-2DD9F996-AB4C-4EDF-B111-5957B2729C33Q37206422-F995EC15-282A-429F-B1E0-AF811E5CE01FQ37675040-1CE032E0-135A-437B-84E5-6C71DCAAA876Q40072965-2A70C319-8656-44BF-9DAB-6FC628A97AD9Q40934127-B9281D2F-BF35-4F21-A572-F279822AF355Q41551955-756A3139-296E-47C5-898E-909404CCDF17Q47140686-76E17621-6E62-4E34-9A1A-2D7A9905EC8FQ47142324-B4DC17DB-4DA5-49A8-A4CD-C1CCA85B0286Q58806292-5F83553A-37E6-4346-B34A-B6E2CF09E68B
P2860
Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Transmitted drug resistance an ...... individuals in New York City.
@ast
Transmitted drug resistance an ...... individuals in New York City.
@en
type
label
Transmitted drug resistance an ...... individuals in New York City.
@ast
Transmitted drug resistance an ...... individuals in New York City.
@en
prefLabel
Transmitted drug resistance an ...... individuals in New York City.
@ast
Transmitted drug resistance an ...... individuals in New York City.
@en
P2093
P2860
P1476
Transmitted drug resistance an ...... individuals in New York City.
@en
P2093
Amir Figueroa
Andrea Low
Brandi Davis
Donald Garmon
Martin Markowitz
Melissa LaMar
Saurabh Mehandru
Sharon Karmon
Teresa Evering
P2860
P356
10.1097/QAI.0B013E31825A289B
P407
P577
2012-09-01T00:00:00Z